Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s00213-014-3518-1

http://scihub22266oqcxt.onion/10.1007/s00213-014-3518-1
suck pdf from google scholar
C4146648!4146648 !24647921
unlimited free pdf from europmc24647921
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24647921 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid24647921
      Psychopharmacology+(Berl) 2014 ; 231 (18 ): 3799-807
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals #MMPMID24647921
  • Schacht JP ; Anton RF ; Randall PK ; Li X ; Henderson S ; Myrick H
  • Psychopharmacology (Berl) 2014[Sep]; 231 (18 ): 3799-807 PMID24647921 show ga
  • RATIONALE: The ?4?2 nicotinic acetylcholine receptor partial agonist varenicline has been reported to reduce drinking among both heavy-drinking smokers and primary alcoholics, and this effect may be related to varenicline-mediated reduction of alcohol craving. Among smokers, varenicline has been reported to modulate cigarette cue-elicited brain activation in several reward-related areas. OBJECTIVES: This pilot study tested varenicline's effects on drinking, alcohol craving, and alcohol cue-elicited activation of reward-related brain areas among non-treatment-seeking alcohol-dependent individuals. METHODS: Thirty-five such individuals (mean age?=?30, 57 % male, 76 % heavy drinking days in the past month, 15 smokers) were randomized to either varenicline (titrated to 2 mg) or placebo for 14 days, and were administered an alcohol cue reactivity fMRI task on day 14. A priori regions of interest (ROIs) were bilateral and medial orbitofrontal cortex (OFC), right ventral striatum (VS), and medial prefrontal cortex (mPFC). RESULTS: Despite good medication adherence, varenicline did not reduce heavy drinking days or other drinking parameters. It did, however, increase self-reported control over alcohol-related thoughts and reduced cue-elicited activation bilaterally in the OFC, but not in other brain areas. CONCLUSIONS: These data indicate that varenicline reduces alcohol craving and some of the neural substrates of alcohol cue reactivity. However, varenicline effects on drinking mediated by cue-elicited brain activation and craving might be best observed among treatment-seekers motivated to reduce their alcohol consumption.
  • |*Reward [MESH]
  • |Adult [MESH]
  • |Alcohol Drinking/*drug therapy/physiopathology/psychology [MESH]
  • |Alcoholism/*drug therapy/physiopathology/psychology [MESH]
  • |Benzazepines/*pharmacology/therapeutic use [MESH]
  • |Brain Mapping [MESH]
  • |Brain/*drug effects/physiopathology [MESH]
  • |Craving/*drug effects [MESH]
  • |Cues [MESH]
  • |Female [MESH]
  • |Humans [MESH]
  • |Magnetic Resonance Imaging [MESH]
  • |Male [MESH]
  • |Middle Aged [MESH]
  • |Motivation [MESH]
  • |Nicotinic Agonists/*pharmacology/therapeutic use [MESH]
  • |Pilot Projects [MESH]
  • |Quinoxalines/*pharmacology/therapeutic use [MESH]
  • |Varenicline [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box